Chien-Chun Yu

Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan.

Ming-Shiang Wu, Chieh-Chang Chen, Jiing‐Chyuan Luo, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan

Ming-Shiang Wu, Chieh-Chang Chen, Wen-Hao Hu, 2020, Journal of gastroenterology and hepatology.

Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.

E. El-Omar, C. Shun, Jaw-Town Lin, 2022, The lancet. Gastroenterology & hepatology.

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.

E. El-Omar, Wen-Lun Wang, C. Shun, 2018, Gastroenterology.

Toward population specific and personalized treatment of Helicobacter pylori infection

Wen-Lun Wang, Jaw-Town Lin, Han-Mo Chiu, 2018, Journal of Biomedical Science.

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial

Wen-Lun Wang, C. Shun, Jaw-Town Lin, 2018, The Journal of antimicrobial chemotherapy.

Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.

E. El-Omar, C. Shun, Jaw-Town Lin, 2023, The lancet. Gastroenterology & hepatology.

Toward population specific and personalized treatment of Helicobacter pylori infection

Wen-Lun Wang, Jaw-Town Lin, Han-Mo Chiu, 2018, Journal of Biomedical Science.